Investor
The company’s digital therapeutic aimed at treating depression in teens, SparkRx, was launched in October.
The Series A will support Proov’s new Complete testing product.
The fund seeks to capitalise on Europe’s rapidly expanding digital health landscape.
2022 Look Ahead
Three experts from AI, analytics and population health IT vendor Health Catalyst share their predictions, which can help CIOs and other health leaders prepare for the year ahead.
This new infusion of cash comes roughly two years after the company closed a $60.75 million Series D round.
The prescription digital therapeutics company said the transaction generated approximately $175 million.
Its app aims to improve the quality of life and survival of cancer patients.
The funding round comes months after the company raised $19.5 million in Series A financing.
A novel telemedicine platform receives significant funding, with video appointments and remote data sharing among its key features.
It is also partnering with Sonic Healthcare to develop new pathology AI tools.